Services
-
Regulatory Phase I Trials
6/23/2011
SGS provides not only safety assessments to comply with EMEA and FDA requirements, but a variety of additional information to facilitate your "GO - NO GO" decisions.
-
Data Management Services
6/22/2011
SGS’s Data Management team has over 15 years of experience providing unparalleled service with an understanding for individual clients’ needs.
-
Bioanalysis
6/21/2011
A dedicated team evaluates assay requests from a strategic and scientific point of view.
-
Immunoanalysis
6/21/2011
SGS has been working in the immunoanalysis field for many years and with its multidisciplinary team of scientists and technicians SGS works with sponsors to address their immunoanalysis needs on a case by case basis.
-
ADME
6/21/2011
SGS’ Life Science Services provides an extensive pharmacokinetic (PK) and pharmacodynamic (PD) support in pre-clinical and Phase I-III clinical studies in accordance with international regulatory standards (FDA, EMEA, ICH).
-
Bioanalytical Assay Method Validation
6/21/2011
A dedicated team evaluates assay requests from a strategic and scientific point of view. Methods proprietary to SGS or the sponsor are developed with focus on high-throughput technological capabilities (TurboFlow extraction, Multiprobe robots).
-
CNS
5/20/2011
Clinical development of products treating diseases of the central nervous system (CNS) is uniquely complex. Challenges include successful and timely patient enrollment, reliance on subjective outcome measures, understanding factors that impact placebo response, and ensuring treatment adherence.
-
Cadiovascular
5/20/2011
Clinical trials in the cardiovascular space have become more complex. You may be facing limited access to capital, growing scrutiny from pharma partners and payers, as well as new requirements from regulatory agencies — all with limited operational resources.
-
Therapeutic Areas
5/20/2011
Deep therapeutic knowledge and understanding of the key issues combined with clinical development experience drives more effective and efficient pathways to commercialization.
-
Medical Writing
5/20/2011
Your clinical development success starts and ends with documenting your research plans and results — but your medical writing demands aren’t always predictable.